Related Experiment Video
Updated: Feb 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Why is the rate of pneumococcal pneumonia declining?
Carlos M Luna1, Laura Pulido, Diego Burgos
1Pulmonary Diseases Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
Streptococcus pneumoniae is now identified in fewer pneumonia cases due to advances in diagnostics, antimicrobial therapy, and widespread vaccination. Pneumococcal conjugate vaccines have significantly reduced invasive pneumococcal disease across all age groups.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Streptococcus pneumoniae was once the primary cause of pneumonia.
- Its role as a leading etiological agent has significantly diminished over the past century.
Purpose of the Study:
- To analyze the reasons behind the declining incidence of Streptococcus pneumoniae as a cause of pneumonia.
- To review the impact of medical advancements on the prevalence of pneumococcal pneumonia.
Main Methods:
- Review of historical data and current epidemiological trends in pneumonia etiology.
- Analysis of the influence of antimicrobial therapy, diagnostic techniques, and preventive measures.
Main Results:
- Decreased identification of S. pneumoniae in pneumonia cases compared to the early 20th century.
- Advancements include new diagnostic tools (PCR, urinary antigens) and improved antimicrobial treatments.
- Widespread use of pneumococcal vaccines (polysaccharide and conjugate) has been highly effective.
Conclusions:
- The decline in S. pneumoniae's role is multifactorial, driven by medical progress.
- Pneumococcal conjugate vaccines have substantially reduced vaccine-type invasive pneumococcal disease through direct and herd immunity effects.
- Ongoing surveillance and vaccination strategies are crucial for managing pneumococcal disease.
Related Concept Videos
Magnetic Declination
Conservation of Declining Populations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Reaction Rate
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

